Treace Medical Concepts, Inc.
TMCI- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001630627
In the last 90 days, Treace Medical Concepts, Inc. insiders filed 1 open-market purchase and 0 sales; 116 institutions reported holding it in 13F filings for Q2 2026, worth $126.8M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Treace Medical Concepts, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Q4 2022 | Change |
|---|---|---|---|
| Holders | 91 | 106 | +15 |
| Shares | 26.1M | 28.4M | +2.26M (+8.7%) |
| Value | $575.8M | $617.6M | +$41.8M (+7.3%) |
New holders (24)
Institutions that held Treace Medical Concepts, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
Sold out (9)
Institutions that held Treace Medical Concepts, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| UBS Oconnor LLC | 132,637 | $2.93M |
| Jane Street Group, LLC | 39,936 | $881.0K |
| SEI Investments Co | 28,282 | $624.0K |
| Cna Financial Corp | 26,994 | $596.0K |
| Marshall Wace, LLP | 23,707 | $524.0K |
| Man Group plc | 20,791 | $459.0K |
| Bank of Montreal | 2,373 | $54.0K |
| Ensign Peak Advisors, Inc | 1,340 | $30.0K |
| Nisa Investment Advisors, LLC | 24 | $1.00K |